Product Information
LYRICA 50 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.7042 per EA under NDC 58151023788. Its NADAC has been published 72 times since Feb 12, 2025.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151023788
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446On Market Since
11/19/2024
Price Statistics
The NADAC for LYRICA 50 MG CAPSULE has been published 72 times since Feb 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7042 per EA |
|---|---|
| All-time high | $9.7423 (Apr 16, 2025) |
| All-time low | $9.6497 (May 21, 2025) |
| 52-week high | $9.7121 |
| 52-week low | $9.6929 |
| Median price | $9.7095 |
| Average price | $9.7047 |
| Largest weekly change | -0.8% (Apr 23, 2025) |
| Weeks tracked | 72 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LYRICA 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 50 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.7042 per EA (NDC 58151023788), effective Jun 24, 2026.
How has the price of LYRICA 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 50 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 72 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for LYRICA 50 MG CAPSULE?
Since Feb 12, 2025, the NADAC for LYRICA 50 MG CAPSULE has ranged from a low of $9.6497 (May 21, 2025) to a high of $9.7423 (Apr 16, 2025), with a median of $9.7095 per EA.
Are there cheaper alternatives to LYRICA 50 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 50 MG CAPSULE, is $0.0463 per EA — about 100% below LYRICA 50 MG CAPSULE.
Who manufactures LYRICA 50 MG CAPSULE?
LYRICA 50 MG CAPSULE (NDC 58151023788) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification